Comprehensive Nutrition for Prostate Health
Description:
Prosta-Support Formula™, provided by DouglasLaboratories, is a synergistic and comprehensivecombination of vitamins, minerals, herbals and othernutrients, carefully formulated and specificallydesigned to support and maintain general health aswell as the health and function of the prostate.
Health Functions:
Prosta-Support Formula™ contains not only the baseformula of Douglas Laboratories'Ultra Specificseries of products that offers intensive support for thehealthy functioning of the body in general, but alsothe Prosta-Support Proprietary Blend providingcompounds that work specifically to maintain thestructure and function of a healthy prostate.Saw Palmetto inhibits the conversion of testosteroneto its more active, and potentially deleterious form,dihydrotestosterone (DHT), via inhibition of alpha-5-reductase. Saw palmetto not only inhibits the bindingof DHT to cellular receptors, but also has alpha1-adrenoceptor-inhibitory properties. Alpha1-adrenoceptor antagonism may be responsible for sawpalmetto's ability to provide support to the urinarytract and prostate. Saw palmetto extracts have alsobeen found to inhibit the biosynthesis ofproinflammatory prostaglandins and leukotrienes. Pygeum extract decreases prolactin and cholesterollevels in the prostate, which in turn decreases uptakeand reduces the number of binding sites fortestosterone in the prostate. In addition, pygeumextract, like saw palmetto, interferes with thesynthesis of proinflammatory prostaglandins.Pumpkin seed and nettles are thought to have similarproperties. Citrus bioflavonoids, vitamin E, vitamin C, zinc andselenium provide potent antioxidant protectionagainst oxidative damage to the prostate. Vitamin D-3 is reported to inhibit cell proliferation andencourage apoptosis. Ingredients:
Formula(#84074-120X)
Four Tablets Contain:
Vitamin A (Palmitate) 5,000 I.U.,Beta-Carotene 15,000 I.U.,Vitamin C (Ascorbic Acid) 1,000 mg,Vitamin D-3 50 I.U.,Vitamin E (as Vitamin E Succinate) 200 I.U.,Thiamin (as Thiamin HCl) 50 mg,Riboflavin 25 mg,Niacin/Niacinamide 120 mg,Vitamin B-6 (as Pyridoxine HCl/Pyridoxal-5-Phosphate Complex) 25 mg,Folic Acid 800 mcg,Vitamin B-12 (on Ion Exchange Resin) 100 mcg,Biotin 300 mcg,Pantothenic Acid (as d-Calcium Pantothenate) 150 mcg,Calcium (from Calcium Citrate/Ascorbate Complex) 300 mg,Magnesium (from Magnesium Aspartate/Ascorbate Complex) 300 mg,Zinc (from Zinc Aspartate Complex) 20 mg,Selenium (Organic Selenium from Krebs† Cycle and Kelp) 200 mcg,Copper (from Copper Amino Acid Chelate) 2 mg,Manganese (from Manganese Aspartate Complex) 15 mg,Chromium (Organically bound with GTF activity-low allergenicity) 200 mcg,Molybdenum (from Molybdenum Krebs†) 50 mcg,Potassium (from Potassium Aspartate Complex) 75 mg,Choline (from Choline Citrate/Bitartrate) 20 mg,Inositol 25 mg,Citrus Bioflavonoid Complex 100 mg,PABA (Para-Aminobenzoic Acid) 50 mg,Vanadium (from Vanadium Krebs†) 25 mcg,Boron (from Boron Aspartate/Citrate Complex) 1 mg,Trace Elements (from Sea Vegetation) 100 mcg,Prosta-Support Proprietary Blend 500 mg.
Saw Palmetto, Pumpkin Seed Powder, Pygeum,Lemon Bioflavonoids, Alfalfa, Buchu, L-Alanine, LGlutamicAcid, Nettles (standardized), Parsley, Uva-Ursi (standardized) and Beta-Carotene.
†Krebs=Citrate, Fumarate, Malate, Glutarate and Succinate Complex.
Servings:
Adults take 4 tablets daily or as directed byphysician. This product is best taken with meals
Caution:
No adverse side effects reported.
Store in a cool, dry place, away from direct light. Keep out of reach of children.
Disclaimer:
The Food and Drug Administration has not evaluated statements contained herein. These products are not intended to diagnose, treat and cure or prevent disease. Always consult with your professional health care provider before changing any medication.
References:
- Bracher F. [Phytotherapy of benign prostatic hyperplasia]. UrologeA 1997;36:10-7.
- Carbin BE, Larsson B, Lindahl O. Treatment of benign prostatichyperplasia with phytosterols. Br J Urol 1990;66:639-41.
- Dogru-Abbasoglu S, Aykac-Toker G, Kocak T, Unluer E, UysalM. Antioxidant enzyme activities and lipid peroxides in the plasmaof patients with benign prostatic hyperplasia or prostate cancer arenot predictive. J Cancer Res Clin Oncol 1999;125:402-4.
- Dreikorn K, Schonhofer PS. [Status of phytotherapeutic drugs intreatment of benign prostatic hyperplasia]. Urologe A1995;34:119-29.
- Fleshner N, Fair WR, Huryk R, Heston WD. Vitamin E inhibits thehigh-fat diet promoted growth of established human prostateLNCaP tumors in nude mice. J Urol 1999;161:1651-4.
- Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA.Saw palmetto (Serenoa repens) in men with lower urinary tractsymptoms: effects on urodynamic parameters and voidingsymptoms. Urology 1998;51:1003-7.
- Goepel M, Hecker U, Krege S, Rubben H, Michel MC. Sawpalmetto extracts potently and noncompetitively inhibit humanalpha1-adrenoceptors in vitro. Prostate 1999;38:208-15.
- Ho SM, Viccione T, Yu M. In vitro and in vivo inhibition ofnuclear type II estrogen binding sites in the dorsolateral prostate ofnoble rats. J Steroid Biochem Mol Biol 1993;46:489-95.
- Komoda Y. Isolation of flavonoids from Populus nigra as delta 4-3-ketosteroid (5 alpha) reductase inhibitors. Chem Pharm Bull(Tokyo) 1989;37:3128-30.
- Lee SC, Kuan CY, Yang CC, Yang SD. Bioflavonoids commonlyand potently induce tyrosine dephosphorylation/inactivation ofoncogenic proline-directed protein kinase FA in human prostatecarcinoma cells. Anticancer Res 1998;18:1117-21.
- Ripple MO, Henry WF, Schwarze SR, Wilding G, Weindruch R.Effect of antioxidants on androgen-induced AP-1 and NF-kappaBDNA- binding activity in prostate carcinoma cells. J Natl CancerInst 1999;91:1227-32.
- Simpson D. Buchu--South Africa's amazing herbal remedy. ScottMed J 1998;43:189-91.
- Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Sawpalmetto extracts for treatment of benign prostatic hyperplasia: asystematic review [published erratum appears in JAMA 1999 Feb10;281(6):515] . Jama 1998;280:1604-9.
|
